AzTrials
AzTrials

Quality of LifePhase 3NCT03304184

The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life

A Phase 3 study testing Photac-fil and Biodentine in people with Quality of Life and Cervical Abrasion, run by University of Michigan at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The study will compare two different dental materials on dental lesions near the gum line that cause chronic pain on oral health related quality of life. Read more about this study

Who is it for?
Ages 18 to 64 years
Conditions the study is for
Quality of Life, Cervical Abrasion
What is being tested?
Photac-fil and Biodentine
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
24 participants
Where
1 siteUnited States
Study dates
28 Sep 2017to 9 Oct 2019
Phase
Phase 3
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 64 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Males and females age 18-64
  • Chief complaint associated with pain from cold or hot
  • Chronic sensitivity associated with supragingival lesions
  • Pain not associated with decay
  • Fluent in English and able to read English at a 6th grade level
  • Pulpal response <40 via pulp tester
  • Active salivary flow from palpation of parotid and submandibular glands
  • Patients self reporting pain over 6/10 in the past week and/or the past 2 months

Who cannot join

  • Pregnant women
  • Patients taking benzodiazepines, narcotics and multiple antidepressants for pain management not associated with the oral cavity
  • Unexplained dry mouth
  • Patients taking two or more medications associated with dry mouth
  • Pulpal response >40 via pulp tester
  • Patients requiring treatment for more than 5 decayed sites, periodontal disease and root canal therapy
  • Complicated medical history (>4 concurrent treatment for systemic diseases)
  • Lesion >1mm below the gum line

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Dental School

    Ann Arbor, Michigan, 48109

Other trials in United States

About this study

The study will compare two different dental materials on dental lesions near the gum line that cause chronic pain on oral health related quality of life.

Read the detailed description

The study will compare two different dental materials on dental lesions near the gum line. One of the materials is tooth colored and the other material is white but both materials use different mechanisms to attach to the teeth and may have different outcomes. The study will determine if one material is more effective in relieving chronic pain. In addition, we will evaluate changes in oral health related quality of life after the placement of the two different dental materials.

Being tested
Photac-fil, Biodentine

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Photac-filDevice

    Also called Resin modified glass ionomer

    Application of a tooth colored filling in a non-cavitated dental lesion.

  • BiodentineDevice

    Application of a white colored filling in a non-cavitated dental lesion.

Study groups in NCT03304184
Study groupRoleWhat they receive
Photac-filPlacebo comparatorParticipants will have a restoration placed with photac-fil in the lesion near the gum line.
Receives: Device: Photac-fil
BiodentineExperimentalParticipants will have a restoration placed with Biodentine in the lesion near the gum line.
Receives: Device: Biodentine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Global Base Changes of Pain

    A one survey description detailing the changes in pain over time based on the following scale:

    1. -No change (or condition has gotten worse)
    2. -Almost the same, hardly any change at all
    3. -A little better, but no noticeable change
    4. -Somewhat better, but the change has not made any real difference
    5. -Moderately better, and a slight but noticeable change
    6. -Better and a definite improvement that has made a real and worthwhile difference
    7. -A great deal better and a considerable improvement that has made all the difference

    Measured: baseline, week1, week 2, 3 month follow up

  2. Oral Health Related Quality of Life Using a Survey With 49 Questions

    A survey of 49 questions to assess oral health related quality of life. The scale measured 49 questions with a yes (1) or no (0) answers with a possible range of 0-49. The more answers of yes will indicate a higher score on the survey, which describes poorer oral health related quality of life. A lower number reflects better oral health related quality of life. A maximum score of 49 is the worst outcome.

    Measured: Baseline, week1, week 2, 3 month follow up

  3. Brief Pain Inventory

    6 questions were used to measure pain on a sliding scale from 1-100 at each time point. The scale ranged from 1 being no pain and 100 being extreme pain. The higher the number reflects worse the pain compared to a lower number. The maximum range from the participants was 600 (maximum) and the lowest range of 0 for all questions. The data reflects the averaged sum for each time point for all patients in each arm.

    Measured: Baseline, week1, week 2, 3 month follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Oct 2017
  2. Study start28 Sep 2017
  3. Primary completion9 Oct 2019
  4. Study completion9 Oct 2019

Why it stopped: COVID

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
One group will be treated with a tooth colored filling that will be placed near the gum line. The second group will be treated with a white colored filling that will be placed near the gum line.
Masking
None (open label)
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03304184
Sponsor's protocol ID
HUM00111890
Status last verified
Jun 2021
First submitted
3 Oct 2017
Last updated
19 Jul 2021
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Photac-fil and Biodentine in people with Quality of Life and Cervical Abrasion, run by University of Michigan at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 19 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 19 Jul 2021). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Global Base Changes of Pain (time frame: baseline, week1, week 2, 3 month follow up). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in